Rucaparib Plus Ramucirumab With or Without Nivolumab in Advanced Gastric and Esophageal Adenocarcinoma
Clinical trial NCT03995017 · UNKNOWN
Trial details
- NCT number
- NCT03995017
- Sponsor
- University of Kansas Medical Center
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-09
- Primary completion
- 2022-10-19
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.